These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

106 related items for PubMed ID: 6230579

  • 21. [Quantitative determination of rubella virus antibodies in capillary blood. A simple, reliable and economic method (author's transl)].
    Zippel C, Federmann G, Leidel J, Eggers HJ.
    MMW Munch Med Wochenschr; 1980 Jun 20; 122(25):943-6. PubMed ID: 6772945
    [Abstract] [Full Text] [Related]

  • 22. Development of a rubella vaccination strategy: contribution of a rubella susceptibility study of women of childbearing age in Kyrgyzstan, 2001.
    Malakmadze N, Zimmerman LA, Uzicanin A, Shteinke L, Caceres VM, Kasymbekova K, Sozina I, Glasser JW, Joldubaeva M, Aidyralieva C, Icenogle JP, Strebel PM, Reef SE.
    Clin Infect Dis; 2004 Jun 15; 38(12):1780-3. PubMed ID: 15227627
    [Abstract] [Full Text] [Related]

  • 23. Rubella susceptibility. Provisional study in a suburban high school population.
    Berman RW, Schell NB.
    N Y State J Med; 1982 Mar 15; 82(3):388-90. PubMed ID: 6953345
    [No Abstract] [Full Text] [Related]

  • 24. Can we prevent an increase in the incidence of congenital rubella syndrome in the next decade?
    Coulombe L, Rosser WW.
    Can Med Assoc J; 1981 Jul 01; 125(1):37-40. PubMed ID: 7260807
    [Abstract] [Full Text] [Related]

  • 25. [Studies on rubella vaccination in adult females. I: Clinical and laboratory studies on clinical reactions].
    Nakazono N.
    Hokkaido Igaku Zasshi; 1984 Mar 01; 59(2):180-91. PubMed ID: 6745839
    [Abstract] [Full Text] [Related]

  • 26. HLA and the rubella-specific immune response following vaccination.
    Van Eden W, UytdeHaag F, Loggen HG, Plantinga AD, De Vries RR, Van Rood JJ.
    Exp Clin Immunogenet; 1984 Mar 01; 1(2):70-4. PubMed ID: 6400993
    [Abstract] [Full Text] [Related]

  • 27. [Rubella immunity 6 to 10 years following vaccination of previously seronegative young girls].
    Zourbas J, Colas J, Boivin M.
    Presse Med; 1983 Mar 12; 12(11):701. PubMed ID: 6220304
    [No Abstract] [Full Text] [Related]

  • 28. [Rubella immunity 5 years after vaccination].
    Zourbas J, Senecal J, Roussey A, Boivin M.
    Nouv Presse Med; 1978 Apr 15; 7(15):1297. PubMed ID: 662659
    [No Abstract] [Full Text] [Related]

  • 29. [Infectious disease control. New and old aspects of rubella].
    Di Nola F, Soranzo ML.
    Minerva Med; 1971 Nov 17; 62(87):4279-83. PubMed ID: 5134758
    [No Abstract] [Full Text] [Related]

  • 30. Study of young women vaccinated against rubella virus for 10 years in Taiwan.
    Lin DB, Kao CL, Lee CY.
    Southeast Asian J Trop Med Public Health; 1996 Dec 17; 27(4):707-14. PubMed ID: 9253871
    [Abstract] [Full Text] [Related]

  • 31. [Anti-rubella vaccination. I. Preliminary results of a trial of anti-rubella vaccination in a sample of the female population].
    Squeri L, Ioli A, Calisto ML, Sindoni L, Capocasale V.
    Ann Sclavo; 1973 Dec 17; 15(1):19-35. PubMed ID: 4775016
    [No Abstract] [Full Text] [Related]

  • 32. Persistence of antibody 10 years after vaccination with Wistar RA27/3 strain live attenuated rubella vaccine.
    Hillary IB, Griffith AH.
    Br Med J; 1980 Jun 28; 280(6231):1580-1. PubMed ID: 7427177
    [No Abstract] [Full Text] [Related]

  • 33. [Effect of vaccination on immune status in pregnancy].
    Topolovec J.
    Lijec Vjesn; 1999 Mar 28; 121(3):73-8. PubMed ID: 10437345
    [Abstract] [Full Text] [Related]

  • 34. Immunogenicity of measles and rubella vaccines in Oman: a prospective clinical trial.
    Kohler KA, Suleiman AJ, Robertson SE, Malankar P, Al-Khusaiby S, Helfand RF, Brown D, Bellini WJ, Sutter RW.
    J Infect Dis; 2003 May 15; 187 Suppl 1():S177-85. PubMed ID: 12721911
    [Abstract] [Full Text] [Related]

  • 35. [Immune status of a school-population sample 5 years after antirubella vaccination].
    Quaglio P, Dattoli A, Mantovani G.
    G Batteriol Virol Immunol; 1982 May 15; 75(7-12):233-8. PubMed ID: 7188256
    [Abstract] [Full Text] [Related]

  • 36. Efforts at rubella elimination in the United States: the impact of hemispheric rubella control.
    Dayan GH, Castillo-Solórzano C, Nava M, Hersh BS, Andrus J, Rodriguez R, Reef SE.
    Clin Infect Dis; 2006 Nov 01; 43 Suppl 3():S158-63. PubMed ID: 16998776
    [Abstract] [Full Text] [Related]

  • 37. Humoral antibody response after rubella vaccination.
    Cubie HA, Burns SM, Collacott IT, Lawson LE.
    Br Med J (Clin Res Ed); 1985 Nov 30; 291(6508):1539-40. PubMed ID: 3933741
    [No Abstract] [Full Text] [Related]

  • 38. [Serological study and anti-rubella vaccination in adolescents].
    Guerrero B, Vergara I, Campodónico I.
    Rev Chil Obstet Ginecol; 1978 Nov 30; 43(3):175-80. PubMed ID: 549170
    [No Abstract] [Full Text] [Related]

  • 39. Seroepidemiology study of rubella antibodies among pregnant women from seven Asian countries: evaluation of the rubella vaccination program in Taiwan.
    Tseng HF, Chang CK, Tan HF, Yang SE, Chang HW.
    Vaccine; 2006 Jul 17; 24(29-30):5772-7. PubMed ID: 16759764
    [Abstract] [Full Text] [Related]

  • 40. Prevalence of HI antibody titer against rubella virus to determine the effect of mass vaccination in Tehran.
    Soleimanjahi H, Bamdad T, Fotouhi F, Roustai MH, Faghihzadeh S.
    J Clin Virol; 2005 Oct 17; 34(2):153-4. PubMed ID: 16076562
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.